Hepatology
Non-alcoholic fatty liver disease and its more aggressive form, non-alcoholic steatohepatitis (NASH), has become the fastest-growing cause.
Non-alcoholic fatty liver disease and its more aggressive form, non-alcoholic steatohepatitis (NASH), has become the fastest-growing cause.
Hepatology
Fatty Liver Diseases
Non-alcoholic fatty liver disease and its more aggressive form, non-alcoholic steatohepatitis (NASH), has become the fastest-growing cause for liver transplantation among young Americans, according to a recent study.
Typically, older adults experience slow progression of fatty liver disease unrelated to alcohol, which can eventually lead to liver cirrhosis. However, due to rising obesity, hypertension, and diabetes, younger people are progressing to end-stage liver disease within their lifetime.
In Texas, in particular, non-alcoholic steatohepatitis is the #1 indication for liver transplantation in adults. It affects 1 in 3 adults and 1 in 10 children.
The best treatment is prevention. It is important to identify fatty liver damage early and then focus on controlling blood pressure, diabetes, weight loss, and a healthy lifestyle to better help patients with fatty liver disease.
Book a visit — we will pick a convenient time.